Polymorphisms in the calcium-sensing receptor gene are associated with clinical outcome of neuroblastoma. - Wikidata - wikimedia - TriplyDB

Polymorphisms in the calcium-sensing receptor gene are associated with clinical outcome of neuroblastoma.

Polymorphisms in the calcium-sensing receptor gene are associated with clinical outcome of neuroblastoma.

http://www.wikidata.org/entity/Q34637949

about

Regulation of Differentiation by Calcium-Sensing Receptor in Normal and Tumoral Developing Nervous System Genetic polymorphisms of CASR and cancer risk: evidence from meta-analysis and HuGE review The role of intracellular calcium for the development and treatment of neuroblastoma.Insights into the Molecular Pathogenesis of Activated B-Cell-like Diffuse Large B-Cell Lymphoma and Its Therapeutic Implications.Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens.Genetic variants in the promoter region of the calcium-sensing receptor gene are associated with its down-regulation in neuroblastic tumors.

P2860

Q26744719-B0E48382-00EA-40EF-A108-3A0E2A401DE3 Q26765295-0777A112-DD31-4446-AC2A-1D8C383DF20D Q35818437-D615E80F-FB71-4F8F-9252-62E04AD3A651 Q35818443-DCC3F2BD-896C-468F-B73E-3187AF107FEC Q37085969-7832CC2F-C5E9-4F39-BBE8-1AFA703E328C Q39175094-FDBB293B-2C44-46D1-8709-AEA2E226E94D

P2860

Polymorphisms in the calcium-sensing receptor gene are associated with clinical outcome of neuroblastoma.

http://www.wikidata.org/entity/Q34637949

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Polymorphisms in the calcium-s ...... ical outcome of neuroblastoma.

@ast

Polymorphisms in the calcium-s ...... ical outcome of neuroblastoma.

@en

Polymorphisms in the calcium-s ...... ical outcome of neuroblastoma.

@nl

type

label

Polymorphisms in the calcium-s ...... ical outcome of neuroblastoma.

@ast

Polymorphisms in the calcium-s ...... ical outcome of neuroblastoma.

@en

Polymorphisms in the calcium-s ...... ical outcome of neuroblastoma.

@nl

prefLabel

Polymorphisms in the calcium-s ...... ical outcome of neuroblastoma.

@ast

Polymorphisms in the calcium-s ...... ical outcome of neuroblastoma.

@en

Polymorphisms in the calcium-s ...... ical outcome of neuroblastoma.

@nl

P1433

Q34637949-18228153-ADE9-4E04-B784-47B7D8B68E14

P1476

Q34637949-C11DEC9B-862E-43D3-A39C-4823EC4A2061

P2093

Q34637949-1250DA18-B389-4DA8-93AF-E1AF84B2E140

Q34637949-57317A9E-1EF1-457A-B543-8BF42C7DD1AF

Q34637949-5C4D0A8E-2D19-464E-8796-229C7C05723A

Q34637949-C1CD410D-AB73-4773-9F0C-FDEBF9E771EE

Q34637949-C65C3E68-1459-40A8-B3D3-551DDEB40EE0

Q34637949-CCC41F28-3F3B-42AC-804B-36A610F23965

Q34637949-D1722E14-F46A-430D-A2AE-59A60ADDDDD2

P2860

Q34637949-0694ECBE-149D-4F40-818A-EC9792569E3F

Q34637949-0CEF0DEC-6E62-4EAB-ABD3-A990450EC258

Q34637949-10A785D8-B60B-4B81-9C42-D8C1F731B64E

Q34637949-1D843A54-71BA-44F9-99BC-23EED5CDD3D5

Q34637949-205DC566-04B5-453F-875A-A34D4BDD6C66

Q34637949-226953F3-EBD8-4297-88D1-E3BD1B59C763

Q34637949-24E150DA-81A5-48A7-B016-DF74332E47F1

Q34637949-2936997F-F37A-4C1B-8FCA-435B10DCAA07

Q34637949-30C7DA7B-28A2-47E7-8A37-FB342F1A0B37

Q34637949-36F252C3-7164-4084-A01A-7069B5DDA3A5

P304

Q34637949-E6CF1CA7-A6DD-41FC-BEB6-67A7B4AD0A76

P31

Q34637949-C03A2316-4AD4-4A63-A65C-4254B19BA256

P356

Q34637949-2ADDA28D-6CDF-48E3-B27B-6597AAC9DDE2

P407

Q34637949-A9D763A4-0460-4679-AC37-E4D04716D319

P433

Q34637949-193798B2-3791-4BD3-AE35-81435C295A13

P478

Q34637949-503BF61D-60D8-4581-9C38-65599BD2D1E6

P50

Q34637949-7E8CD34E-D457-4C3B-8C54-5FF846D9BAE0

P577

Q34637949-339FB149-5EE1-4643-99C6-DF264EE2AC12

P5875

Q34637949-4F9ABC48-91C7-4710-9968-41B0CDBAFCF6

P698

Q34637949-FDF3B650-D2AE-4D40-806F-0FD23D539D3D

P932

Q34637949-6F3A691C-3F97-481D-800F-32C89657A292

P356

JOURNAL.PONE.0059762

P1433

P1476

Polymorphisms in the calcium-s ...... ical outcome of neuroblastoma.

@en

P2093

Carla Casalà

http://www.w3.org/2001/XMLSchema#string

Carmen de Torres

http://www.w3.org/2001/XMLSchema#string

Cinzia Lavarino

http://www.w3.org/2001/XMLSchema#string

Eva Rodríguez

http://www.w3.org/2001/XMLSchema#string

Laia Masvidal

http://www.w3.org/2001/XMLSchema#string

Patricia Galván

http://www.w3.org/2001/XMLSchema#string

Raquel Iniesta

http://www.w3.org/2001/XMLSchema#string

P2860

Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation

Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

Chromosome 6p22 locus associated with clinically aggressive neuroblastoma

Nonparametric Estimation from Incomplete Observations

The structure of haplotype blocks in the human genome

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma

Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains.

Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid

P304

e59762

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0059762

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236085180

http://www.w3.org/2001/XMLSchema#string

P698

23533647

http://www.w3.org/2001/XMLSchema#string

P932

3606108

http://www.w3.org/2001/XMLSchema#string